Cargando…

Atherosclerosis and Other Related-Arterial Diseases

Detalles Bibliográficos
Autores principales:	Blanco-Colio, Luis M., Martín-Ventura, Jose L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341413/ https://www.ncbi.nlm.nih.gov/pubmed/37445629 http://dx.doi.org/10.3390/ijms241310453

Ejemplares similares

Red Blood Cells and Hemoglobin in Human Atherosclerosis and Related Arterial Diseases
por: Michel, Jean-Baptiste, et al.
Publicado: (2020)

Role of Extracellular Vesicles as Potential Diagnostic and/or Therapeutic Biomarkers in Chronic Cardiovascular Diseases
por: Martin-Ventura, Jose Luis, et al.
Publicado: (2022)

Inflammation, Atherosclerosis and Coronary Artery Disease
por: Momiyama, Yukihiko, et al.
Publicado: (2016)

Protection of diabetes in aortic abdominal aneurysm: Are antidiabetics the real effectors?
por: Picatoste, Belén, et al.
Publicado: (2023)

TWEAK/Fn14 Axis: A Promising Target for the Treatment of Cardiovascular Diseases
por: Blanco-Colio, Luis M.
Publicado: (2014)

Targeted gold-coated iron oxide nanoparticles for CD163 detection in atherosclerosis by MRI
por: Tarin, Carlos, et al.
Publicado: (2015)

Annexins and cardiovascular diseases: Beyond membrane trafficking and repair
por: Méndez-Barbero, Nerea, et al.
Publicado: (2022)

Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice
por: Sastre, Cristina, et al.
Publicado: (2014)

The Estimated Absolute Risk of Coronary Artery Disease and Subclinical Atherosclerosis
por: Kadota, Aya
Publicado: (2021)

Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors
por: Tuñón, José, et al.
Publicado: (2007)

Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK)/Fibroblast Growth Factor-Inducible 14 (Fn14) Axis in Cardiovascular Diseases: Progress and Challenges
por: Méndez-Barbero, Nerea, et al.
Publicado: (2020)

Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis
por: López-Mejías, Raquel, et al.
Publicado: (2017)

Immunopathology of Atherosclerosis and Related Diseases: Focus on Molecular Biology
por: Bezsonov, Evgeny E., et al.
Publicado: (2021)

Neutrophil-to-Lymphocyte Ratio for Risk Assessment in Coronary Artery Disease and Carotid Artery Atherosclerosis
por: Park, Jun-Bean
Publicado: (2016)

Animal Models of Cardiovascular Diseases
por: Zaragoza, Carlos, et al.
Publicado: (2011)

Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm
por: Roldán-Montero, Raquel, et al.
Publicado: (2022)

Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets
por: Martin-Ventura, Jose Luis, et al.
Publicado: (2017)

Sortilin and atherosclerosis
por: Mortensen, Martin B., et al.
Publicado: (2015)

N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease
por: Tuñón, José, et al.
Publicado: (2015)

Atherosclerosis as an inflammatory disease: Doubts? No more
por: Vaccarezza, Mauro, et al.
Publicado: (2018)

TWEAK blockade decreases atherosclerotic lesion size and progression through suppression of STAT1 signaling in diabetic mice
por: Fernández-Laso, Valvanera, et al.
Publicado: (2017)

Anti-Inflammatory Drugs in Patients with Ischemic Heart Disease
por: Pello Lázaro, Ana María, et al.
Publicado: (2021)

Monocyte Chemoattractant Protein-1 Is an Independent Predictor of Coronary Artery Ectasia in Patients with Acute Coronary Syndrome
por: Franco-Peláez, Juan Antonio, et al.
Publicado: (2020)

Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease
por: Martín-Reyes, Roberto, et al.
Publicado: (2016)

Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis
por: Núñez, Estefanía, et al.
Publicado: (2022)

Atherosclerosis and Autoimmunity
por: Spinelli, Francesca Romana, et al.
Publicado: (2018)

Inflammation and Atherosclerosis
por: Ley, Klaus
Publicado: (2021)

Lipids and Lipoproteins in Atherosclerosis
por: Bezsonov, Evgeny, et al.
Publicado: (2023)

Lipids and Lipoproteins in Atherosclerosis
por: Chroni, Angeliki, et al.
Publicado: (2011)

Atherosclerosis in Rheumatoid Arthritis
por: González-Gay, Miguel A., et al.
Publicado: (2012)

Accelerated atherosclerosis in HGPS
por: Hamczyk, Magda R., et al.
Publicado: (2018)

Atherosclerosis & ischaemic heart disease: Here to stay or gone tomorrow
por: Ndrepepa, Gjin
Publicado: (2017)

NT-proBNP Levels Influence the Prognostic Value of Mineral Metabolism Biomarkers in Coronary Artery Disease
por: Martínez-Milla, Juan, et al.
Publicado: (2022)

Opening already occluded middle cerebral artery, internal carotid artery or other cerebral arteries: when, where, how and why?
por: Wang, David, et al.
Publicado: (2017)

Nanoporous Gold and Other Related Materials
por: Stine, Keith J.
Publicado: (2019)

Editorial of the VSI “Environmental, ecological and public health considerations regarding coronaviruses, other viruses, and other microorganisms potentially causing pandemic diseases”
por: Núñez-Delgado, Avelino, et al.
Publicado: (2021)

Intravital imaging of leukocyte behavior in atherosclerosis
por: Li, Wenjun, et al.
Publicado: (2019)

Not All Quiet on the Atherosclerosis Front
por: Schäfer, Katrin
Publicado: (2023)

Comprehensive Assessment of Polyvascular Atherosclerosis
por: Nakanishi, Rine, et al.
Publicado: (2018)

MSC - targets for atherosclerosis therapy
por: Colmegna, Ines, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lb9i2ulp1f12bgsngmp9ii60gs